Navigation Links
Anadys Pharmaceuticals Reports Third Quarter 2010 Financial Results and Highlights
Date:11/8/2010

ect program, the Company's pro forma cash balance at September 30, 2010 was $42.7 million.

Total operating expenses were $4.0 million for the third quarter of 2010, compared to $6.0 million for the third quarter of 2009.  Included as a component of Anadys' operating expenses were non-cash, share-based expenses of $0.5 million and $0.6 million for the third quarter of 2010 and 2009, respectively.

Research and development expenses were $2.5 million for the third quarter of 2010, compared to $4.0 million for the third quarter of 2009.  The $1.5 million decrease was primarily attributable to a $0.5 million decrease in ANA773 development costs, a $0.3 million decrease in ANA598 development costs and to a lesser extent personnel and facility cost savings.

General and administrative expenses were $1.5 million for the third quarter of 2010, compared to $2.0 million for the third quarter of 2009.  The $0.5 million decrease was partially attributable to the inclusion of $0.2 million of severance related costs in the third quarter of 2009.  The additional decrease primarily resulted from fluctuations in costs associated with the Company's patent portfolio and to a lesser extent personnel cost savings.  

The net loss was $4.7 million for the third quarter of 2010, compared to a net loss of $7.7 million for the third quarter of 2009.  Included in the net loss for the third quarter of 2010 is a $0.8 million loss resulting from an increase in the liability from June 30, 2010 to September 30, 2010 associated with common stock warrants that were issued in connection with a "registered direct" offering in 2009.  Basic and diluted net loss per common share was $0.11 in the third quarter of 2010, compared to $0.21 in the third quarter of 2009.  Non-cash share-based expense resulted in a $0.01 and $0.02 increase in basic and diluted net loss per share for the third quarter of 2010 and 2009, respectively.

For th
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
2. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
3. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV
6. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
7. Anadys Pharmaceuticals to Present at the JMP Securities Healthcare Focus Conference
8. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
9. Anadys Pharmaceuticals Commences Dosing in Phase II Study of ANA598
10. Anadys Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Anadys Pharmaceuticals to Present at the Oppenheimer Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... May 16, 2013  Today, the National Patient Advocate ... House of Representatives recently approved a bill that ... charging patients higher out-of-pocket fees for newer, more expensive ... which have more severe side-effects. However, the bill was ... which will continue to be a barrier to patients ...
(Date:5/16/2013)... May 16, 2013  Amgen (NASDAQ: AMGN ) ... Tuesday, May 21, 2013, at the Sheraton New York Times ... at 10:00 a.m. Eastern Daylight Time. Joseph P. ... and Development at Amgen, will present at the conference. Live ... Calendar on Amgen,s website, www.amgen.com , under Investors. A ...
(Date:5/16/2013)... Texas , May 16, 2013  ULURU Inc. (OTCQB: ... ended March 31, 2013 and provided a review of its ... the Company is confirming the previously communicated outlook for 2013: ... , Expanding the network of distribution partners to cover ... , Positioning Altrazeal ® to be marketed in ...
Breaking Medicine Technology:National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 2National Patient Advocate Foundation Responds to N.C. State House Approval of Flawed Cancer Treatment Fairness Bill 3ULURU Inc. Reports First Quarter 2013 Financial Results 2ULURU Inc. Reports First Quarter 2013 Financial Results 3ULURU Inc. Reports First Quarter 2013 Financial Results 4ULURU Inc. Reports First Quarter 2013 Financial Results 5
... Bionovo, Inc. (Nasdaq: BNVI, BNVID), a drug discovery and development ... today announced that Dr. Isaac Cohen, O.M.D, Chairman and Chief ... be presenting at a Cambria Capital investor meeting at 4:00 ... be held at Yorgio,s Restaurant in Salt Lake City, UT. ...
... AMGN ) will participate in the Baird Healthcare Conference ... York in New York City, beginning at 12:15 p.m. Eastern ... for Amgen, will present at the conference. Live audio of ... be accessed from Amgen,s website, www.amgen.com , under Investors. ...
Cached Medicine Technology:Bionovo to Present at Cambria Capital Investor Meeting 2Bionovo to Present at Cambria Capital Investor Meeting 3
(Date:5/19/2013)... 2013 Actos lawsuit claims ... underway in U.S. District Court, Western District of Louisiana. ... 3rd, the Court has modified the litigation’s Bellwether Nomination ... rather than four. The next Status Conference in the ... (In re: Actos Product Liability Litigation, MDL No. 2299) ...
(Date:5/19/2013)... 2013 Grinding your teeth at night ... or annoying your spouse. At the same time, according ... (“Snoring and Teeth Grinding Could Be a Sign of ... can be hard to prevent. Apparently, Obstructive Sleep Disorder ... of its symptoms is a habit of teeth grinding ...
(Date:5/19/2013)... (PRWEB) May 19, 2013 These ... for US, UK, Spain, Japan, Italy, Germany and ... the molecular diagnostics laboratory practice, as well as ... with significant market impact during the next five ... probe and biochip technologies, test formats, detection methodologies, ...
(Date:5/19/2013)... York (PRWEB) May 19, 2013 The ... Case Management Conference was recently convened for hundreds of ... multidistrict litigation now underway in U.S. District Court, Southern ... the Court’s website on May 14th, the Conference addressed ... was also reported during the Conference that Defendants submitted ...
(Date:5/19/2013)... Keith Chertok now provides gum disease patients with a new ... chance of a healthier smile. Laser gum surgery ... removes diseased gum tissue in patients, but it also stimulates ... implants. , LANAP uses a laser to successfully treat ... the healthy tissue as well as encourage new bone growth. ...
Breaking Medicine News(10 mins):Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 2Health News:Actos Lawyers at Bernstein Liebhard LLP Note Issuance of New Case Management Order in Federal Actos Bladder Cancer Litigation 3Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 2Health News:Dr. Kanani, Woodland Hills Dentist: Dangers of Tooth Damage and Obstructive Sleep Disorder 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 2Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 3Health News:Molecular Diagnostics Market - US, UK, Spain, Japan, Italy, Germany & France Analysis in New Research Report at ReportsnReports.com 4Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 2Health News:Pradaxa Lawyers at Bernstein Liebhard LLP Report on Recent Status Conference in Federal Pradaxa Litigation 3Health News:Berkeley, CA Periodontist, Dr. Keith Chertok Now Treats Gum Disease Patients With Laser Gum Surgery Prior to Placing Dental Implants 2
... Mental health issues also more common after war, studies show, ... new studies confirm that the effects of war linger long ... the Journal of the American Medical Association is ... three studies published in that issue found that various mental ...
... It Did with Alicia Keys Concert in,Indonesia, ... in,recent weeks, international tobacco control advocates are calling ... promotion of a major,concert, this time in the ... law., Last month, Philip Morris International withdrew ...
... Dr. Richard Bezozo Offers Tips for Early Detection: Screenings Can Save ... ... sun,is coming to an end, are you at risk for developing skin cancer? One ... deadliest form of skin cancer so, now is the time to get,your skin checked ...
... of Southern California (USC) found that overweight Hispanic children ... by higher than normal blood glucose levels that are ... The persistence of pre-diabetes during growth is associated with ... study, which will be published in an upcoming issue ...
... 2007, ROCHESTER, N.Y., Aug. 12 VirtualScopics, Inc.,(Nasdaq: ... for clinical,trials, announced today that revenues for the first ... increase over prior year,s comparable period.,Revenues for the second ... to $1.5 million in the second quarter of 2007. ...
... Internet,shopping today offers many benefits. You can research a ... most anything by clicking a mouse.,But should we be ... traditional office visit or conversation with a physician? In,the ... and,several colleagues compare the relative safety of two systems ...
Cached Medicine News:Health News:Drinking Problems Greater Among Returning Combat Veterans 2Health News:Drinking Problems Greater Among Returning Combat Veterans 3Health News:Philip Morris International Caught in Philippines in Another Concert Sponsorship 2Health News:Philip Morris International Caught in Philippines in Another Concert Sponsorship 3Health News:Skin Cancer is the Fastest Growing Cancer in the U.S. 2Health News:Overweight Hispanic children at significant risk for pre-diabetes, according to new USC study 2Health News:VirtualScopics Reports Second Quarter 2008 Results 2Health News:VirtualScopics Reports Second Quarter 2008 Results 3Health News:VirtualScopics Reports Second Quarter 2008 Results 4Health News:VirtualScopics Reports Second Quarter 2008 Results 5Health News:Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications 2Health News:Researchers Examine Safety of Internet Prescriber Service Providing Erectile Dysfunction Medications 3
Conforms to the convexity of the lens providing easier access to anterior capsule. Reduces pontential of corneal touch. 23G x 5/8in (.60 x 16mm)...
... surgery and other types of refractive surgery. ... stromal bed. Flattened tip provides easy insertion ... flap edge. Multiple ports provide multi-directional irrigation. ... 9mm from end. Two .15mm ports 2mm ...
... product designed for LASIK surgery and ... to irrigate the corneal interface and/or ... insertion under the flap and helps ... provide multi-directional irrigation. 21G x 7/8in ...
Cannula tip is specially rounded, extra smooth for safe insertion through wound and manipulation in the anterior chamber. 27G x 7/8 in (.40 x 22mm)....
Medicine Products: